PACIFIC SELECT FUND
Health Sciences Portfolio
$401.18M
Avg Monthly Net Assets
$416.42M
Total Assets
$432K
Total Liabilities
$415.99M
Net Assets
Health Sciences Portfolio is an Underlying fund in PACIFIC SELECT FUND
,
based in California,
United States of America.
The fund has two share classes
and monthly net assets of $401.18M.
On August 12th, 2024 it reported 124 holdings, the largest
being Eli Lilly & Co (10.7%), UnitedHealth Group Inc (7.9%) and Boston Scientific Corp (5.6%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Ticker | Monthly Returns (2 years) |
|---|---|---|---|
| Class I | C000078112 | ||
| Class P | C000098971 |
Holdings
From latest NPORT-P, filed August 12th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Long | Equity-common | US | $247K | 12K | 0.06 |
| Abbott Laboratories | Long | Equity-common | US | $12M | 112K | 2.80 |
| AbbVie Inc | Long | Equity-common | US | $18M | 104K | 4.30 |
| AC Immune SA | Long | Equity-common | CH | $212K | 53K | 0.05 |
| Agilent Technologies Inc | Long | Equity-common | US | $2M | 16K | 0.50 |
| Align Technology Inc | Long | Equity-common | US | $1M | 6K | 0.32 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $170K | 73K | 0.04 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $6M | 24K | 1.42 |
| Amgen Inc | Long | Equity-common | US | $16M | 51K | 3.83 |
| Argenx SE | Long | Equity-common | NL | $4M | 9K | 0.98 |
| AstraZeneca PLC | Long | Equity-common | GB | $3M | 19K | 0.71 |
| Autolus Therapeutics PLC | Long | Equity-common | GB | $153K | 44K | 0.04 |
| Avantor Inc | Long | Equity-common | US | $808K | 38K | 0.19 |
| Avidity Biosciences Inc | Long | Equity-common | US | $493K | 12K | 0.12 |
| Baxter International Inc | Long | Equity-common | US | $1M | 41K | 0.33 |
| Beam Therapeutics Inc | Long | Equity-common | US | $329K | 14K | 0.08 |
| Becton Dickinson & Co | Long | Equity-common | US | $5M | 23K | 1.28 |
| BeiGene Ltd | Long | Equity-common | KY | $654K | 5K | 0.16 |
| Bio-Techne Corp | Long | Equity-common | US | $807K | 11K | 0.19 |
| Biogen Inc | Long | Equity-common | US | $7M | 29K | 1.59 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $3M | 31K | 0.61 |
| Blueprint Medicines Corp | Long | Equity-common | US | $2M | 18K | 0.47 |
| Boston Scientific Corp | Long | Equity-common | US | $23M | 302K | 5.59 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $290K | 11K | 0.07 |
| Cabaletta Bio Inc | Long | Equity-common | US | $150K | 20K | 0.04 |
| CareMax Inc | Derivative-equity | US | $66.72 | 4K | 0.00 | |
| Cencora Inc | Long | Equity-common | US | $9M | 42K | 2.28 |
| Centene Corp | Long | Equity-common | US | $3M | 39K | 0.62 |
| CG oncology Inc | Long | Equity-common | US | $352K | 11K | 0.08 |
| Cigna Group/The | Long | Equity-common | US | $7M | 21K | 1.70 |
| CONTRA ABIOMED INC | Derivative-equity | US | $22K | 11K | 0.01 | |
| CONTRA FREQUENCY THERA | Derivative-equity | US | $0.02 | 20K | 0.00 | |
| CONTRA MIRATI THERAPEU | Derivative-equity | US | $8K | 11K | 0.00 | |
| Cooper Cos Inc/The | Long | Equity-common | US | $4M | 42K | 0.87 |
| CureVac NV | Long | Equity-common | NL | $69K | 20K | 0.02 |
| Daiichi Sankyo Co Ltd | Long | Equity-common | JP | $831K | 24K | 0.20 |
| Danaher Corp | Long | Equity-common | US | $13M | 53K | 3.17 |
| Denali Therapeutics Inc | Long | Equity-common | US | $556K | 24K | 0.13 |
| Dexcom Inc | Long | Equity-common | US | $3M | 25K | 0.67 |
| Dyne Therapeutics Inc | Long | Equity-common | US | $586K | 17K | 0.14 |
| Edwards Lifesciences Corp | Long | Equity-common | US | $5M | 52K | 1.15 |
| Elanco Animal Health Inc | Long | Equity-common | US | $717K | 50K | 0.17 |
| Elevance Health Inc | Long | Equity-common | US | $13M | 23K | 3.02 |
| Eli Lilly & Co | Long | Equity-common | US | $45M | 49K | 10.74 |
| Exact Sciences Corp | Long | Equity-common | US | $556K | 13K | 0.13 |
| FIXED INC CLEARING CORP.REPO (Fixed Income Clearing Corp.) | Long | Repurchase agreement | US | $9M | – | 2.23 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $2M | 29K | 0.54 |
| Genmab A/S | Long | Equity-common | DK | $504K | 2K | 0.12 |
| Genmab A/S | Long | Equity-common | DK | $344K | 14K | 0.08 |
| Gilead Sciences Inc | Long | Equity-common | US | $3M | 38K | 0.62 |
| Glaukos Corp | Long | Equity-common | US | $424K | 4K | 0.10 |
| Guardant Health Inc | Long | Equity-common | US | $481K | 17K | 0.12 |
| HCA Healthcare Inc | Long | Equity-common | US | $5M | 15K | 1.15 |
| Helix Acquisition Corp II | Long | Equity-common | KY | $431K | 42K | 0.10 |
| Humana Inc | Long | Equity-common | US | $4M | 10K | 0.90 |
| IDEXX Laboratories Inc | Long | Equity-common | US | $3M | 5K | 0.60 |
| Immatics NV | Long | Equity-common | NL | $172K | 15K | 0.04 |
| Immunocore Holdings PLC | Long | Equity-common | GB | $291K | 9K | 0.07 |
| Incyte Corp | Long | Equity-common | US | $636K | 10K | 0.15 |
| Insmed Inc | Long | Equity-common | US | $2M | 31K | 0.49 |
| Inspire Medical Systems Inc | Long | Equity-common | US | $532K | 4K | 0.13 |
| Intuitive Surgical Inc | Long | Equity-common | US | $13M | 30K | 3.21 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $613K | 13K | 0.15 |
| IQVIA Holdings Inc | Long | Equity-common | US | $965K | 5K | 0.23 |
| Johnson & Johnson | Long | Equity-common | US | $8M | 57K | 1.99 |
| Kyverna Therapeutics Inc | Long | Equity-common | US | $49K | 7K | 0.01 |
| Labcorp Holdings Inc | Long | Equity-common | US | $929K | 5K | 0.22 |
| Legend Biotech Corp | Long | Equity-common | KY | $977K | 22K | 0.23 |
| Longboard Pharmaceuticals Inc | Long | Equity-common | US | $54K | 2K | 0.01 |
| Masimo Corp | Long | Equity-common | US | $2M | 15K | 0.45 |
| McKesson Corp | Long | Equity-common | US | $10M | 17K | 2.40 |
| Medtronic PLC | Long | Equity-common | IE | $3M | 36K | 0.69 |
| Merck & Co Inc | Long | Equity-common | US | $16M | 127K | 3.78 |
| Merus NV | Long | Equity-common | NL | $920K | 16K | 0.22 |
| Mettler-Toledo International Inc | Long | Equity-common | US | $1M | 800 | 0.27 |
| Moderna Inc | Long | Equity-common | US | $3M | 23K | 0.65 |
| MoonLake Immunotherapeutics | Long | Equity-common | KY | $305K | 7K | 0.07 |
| Morphic Holding Inc | Long | Equity-common | US | $181K | 5K | 0.04 |
| Nautilus Biotechnology Inc | Long | Equity-common | US | $32K | 14K | 0.01 |
| Neurocrine Biosciences Inc | Long | Equity-common | US | $922K | 7K | 0.22 |
| Novo Nordisk A/S | Long | Equity-common | DK | $5M | 33K | 1.12 |
| Novocure Ltd | Long | Equity-common | JE | $345K | 20K | 0.08 |
| Nurix Therapeutics Inc | Long | Equity-common | US | $637K | 31K | 0.15 |
| Nuvalent Inc | Long | Equity-common | US | $642K | 8K | 0.15 |
| Nuvation Bio Inc | Derivative-equity | US | $555.52 | 3K | 0.00 | |
| Nyxoah SA | Long | Equity-common | BE | $143K | 20K | 0.03 |
| Orchestra BioMed Holdings Inc | Long | Equity-common | US | $101K | 12K | 0.02 |
| Penumbra Inc | Long | Equity-common | US | $1M | 8K | 0.35 |
| Pfizer Inc | Long | Equity-common | US | $6M | 217K | 1.46 |
| Prime Medicine Inc | Long | Equity-common | US | $85K | 17K | 0.02 |
| Protagonist Therapeutics Inc | Long | Equity-common | US | $663K | 19K | 0.16 |
| PTC Therapeutics Inc | Long | Equity-common | US | $416K | 14K | 0.10 |
| QIAGEN NV | Long | Equity-common | NL | $966K | 24K | 0.23 |
| Quest Diagnostics Inc | Long | Equity-common | US | $1M | 8K | 0.25 |
| Rapid Micro Biosystems Inc | Long | Equity-common | US | $3K | 4K | 0.00 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $7M | 6K | 1.59 |
| REGENXBIO Inc | Long | Equity-common | US | $150K | 13K | 0.04 |
| Repligen Corp | Long | Equity-common | US | $704K | 6K | 0.17 |
| REVOLUTION Medicines Inc | Long | Equity-common | US | $524K | 14K | 0.13 |
| Rhythm Pharmaceuticals Inc | Long | Equity-common | US | $1M | 33K | 0.33 |
| Rocket Pharmaceuticals Inc | Long | Equity-common | US | $271K | 13K | 0.07 |
| Roivant Sciences Ltd | Long | Equity-common | BM | $415K | 39K | 0.10 |
| Sage Therapeutics Inc | Long | Equity-common | US | $102K | 9K | 0.02 |
| Sagimet Biosciences Inc | Long | Equity-common | US | $51K | 15K | 0.01 |
| Sanofi SA | Long | Equity-common | FR | $2M | 18K | 0.43 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $2M | 14K | 0.52 |
| Soleno Therapeutics Inc | Long | Equity-common | US | $339K | 8K | 0.08 |
| STERIS PLC | Long | Equity-common | IE | $1M | 7K | 0.35 |
| Stoke Therapeutics Inc | Long | Equity-common | US | $646K | 48K | 0.16 |
| Structure Therapeutics Inc | Long | Equity-common | KY | $566K | 14K | 0.14 |
| Stryker Corp | Long | Equity-common | US | $11M | 34K | 2.75 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $14M | 26K | 3.39 |
| TScan Therapeutics Inc | Long | Equity-common | US | $197K | 34K | 0.05 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $398K | 10K | 0.10 |
| UnitedHealth Group Inc | Long | Equity-common | US | $33M | 64K | 7.88 |
| Vaxcyte Inc | Long | Equity-common | US | $1M | 19K | 0.35 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $9M | 18K | 2.06 |
| Viking Therapeutics Inc | Long | Equity-common | US | $929K | 18K | 0.22 |
| Voyager Therapeutics Inc | Long | Equity-common | US | $175K | 22K | 0.04 |
| West Pharmaceutical Services Inc | Long | Equity-common | US | $2M | 7K | 0.55 |
| Xenon Pharmaceuticals Inc | Long | Equity-common | CA | $946K | 24K | 0.23 |
| Zealand Pharma A/S | Long | Equity-common | DK | $385K | 3K | 0.09 |
| ZEALAND PHARMA A/S | Long | Equity-common | DK | $673K | 5K | 0.16 |
| Zoetis Inc | Long | Equity-common | US | $3M | 16K | 0.68 |
Address
PACIFIC SELECT FUND
700 NEWPORT CTR DR
P O BOX 7500
NEWPORT BEACH
California
92660
United States of America
Directors
Lucie H. Moore
Nooruddin (Rudy) Veerjee
Paul A. Keller
Adrian S. Griggs
Andrew J. Iseman
Gale K. Caruso
Transfer Agents
State Street Bank and Trust Company
Pacific Life Insurance Company
Pricing Services
London Stock Exchange Group PLC
S&P Global Inc.
Bloomberg L.P.
ICE Data Services, Inc.
PricingDirect Inc.
Custodians
Standard Chartered Bank (Jakarta, Jakarta, ID, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Sydney, NSW, AU, Branch)
Mizuho Bank, Ltd. (Minato ku, Tokyo, JP, Branch)
Euroclear Bank
Citibank Europe Public Limited Company (Budapest, HU, Branch)
Standard Chartered International Commercial Bank Co., Ltd.
Standard Chartered Bank (Johannesburg, Gauteng, ZA, Branch)
Skandinaviska Enskilda Banken A/S
Citibank, National Association (Sao Paulo, Sao Paulo, BR, Branch)
Citibank del Peru S.A.
The Hongkong and Shanghai Banking Corporation Limited (Auckland, Auckland, NZ, Branch)
Standard Chartered Bank (Thai) Public Company Limited
Skandinaviska Enskilda Banken AB (Oslo, Oslo, NO, Branch)
State Street Bank International GmbH
UniCredit Bank Austria AG
UBS Switzerland AG
State Street Trust Company Canada
The Hongkong and Shanghai Banking Corporation Limited (Jung-gu, Seoul, KR, Branch)
Citibank, National Association (Singapore, SG, Branch)
State Street Bank and Trust Company (Edinburgh, GB, Branch)
Royal Bank of Canada
Stanbic IBTC Bank PLC
BNP Paribas
Joint Stock Company 'Commercial Bank CitiBank'
Citibank Europe Public Limited Company
Skandinaviska Enskilda Banken AB (Helsinki, Uusimaa, FI, Branch)
Bank Handlowy w Warszawie Spolka Akcyjna
Intesa Sanpaolo S.p.A.
Skandinaviska Enskilda Banken AB
The Hongkong and Shanghai Banking Corporation Limited
Citibank, National Association (Cairo, Cairo, EG, Branch)
State Street Bank and Trust Company
Bank Hapoalim B.M.
BNP Paribas (Athens, Attica, GR, Branch)
Banco Nacional de Mexico, S.A., Integrante del Grupo Financiero Banamex
Deutsche Bank Aktiengesellschaft (Mumbai, Maharashtra, IN, Branch)
Citibank, Anonim Sirketi
Standard Chartered Bank Malaysia Berhad
Standard Chartered Bank (Makati City, Metro Manila, PH, Branch)
Shareholder Servicing Agents
Pacific Select Distributors, LLC
Admins
Pacific Life Insurance Company
Brokers
UBS Securities LLC
Exane, Inc.
CLSA Americas, LLC
Citigroup Global Markets Inc.
J.P. Morgan Securities LLC
Goldman Sachs & Co. LLC
BofA Securities, Inc.
Morgan Stanley & Co. LLC
Nomura Securities International, Inc.
Jefferies LLC